Clinical Trial

Local Registry of Central Nervous System Infections (ReCeNSI)

Study acronym: ReCeNSI
Recruiting
View on ClinicalTrials.gov →
Summary
Central Nervous System (CNS) infections are considered rare conditions but at the same time, they are emergencies whose diagnosis and treatment are time-dependent. They include several clinical syndromes, including meningitis, encephalitis, brain abscesses, and post-surgical meningitis. The classic triad of symptoms includes fever, altered mental status, and neck stiffness, but other common manifestations include nausea and vomiting, cranial nerve dysfunction, skin rash, and seizures. Due to the potentially life-threatening effects on patients, these clinical conditions cannot be underestimated. The CNS includes the brain and spinal cord, surrounded and protected by the meninges and cerebrospinal fluid (CSF). Within the CNS are numerous nuclei responsible for vital functions, as well as more complex intellectual activities.
Trial Details
NCT Number NCT07364539
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions Central Nervous System (CNS) Infection
Enrollment 520 participants
Start Date 2022-03-04
Primary Completion 2022-03-05 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-23